<VariationArchive RecordType="classified" VariationID="12799" VariationName="NM_004959.5(NR5A1):c.18del (p.Asp6fs)" VariationType="Deletion" Accession="VCV000012799" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-11-17" MostRecentSubmission="2017-11-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27838" VariationID="12799">
      <GeneList>
        <Gene Symbol="NR5A1" FullName="nuclear receptor subfamily 5 group A member 1" GeneID="2516" HGNC_ID="HGNC:7983" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q33.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="124481236" stop="124507399" display_start="124481236" display_stop="124507399" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="127243514" stop="127269698" display_start="127243514" display_stop="127269698" Strand="-" />
          </Location>
          <OMIM>184757</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR5A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR5A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004959.5(NR5A1):c.18del (p.Asp6fs)</Name>
      <CanonicalSPDI>NC_000009.12:124503377:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q33.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="124503378" stop="124503378" display_start="124503378" display_stop="124503378" variantLength="1" positionVCF="124503377" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="127265657" stop="127265657" display_start="127265657" display_stop="127265657" variantLength="1" positionVCF="127265656" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D6fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.127265657del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.127265657del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.124503378del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.124503378del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008176.1" sequenceAccession="NG_008176" sequenceVersion="1" change="g.9043del">
            <Expression>NG_008176.1:g.9043del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_051350.1" sequenceAccession="NG_051350" sequenceVersion="1" change="g.11del">
            <Expression>NG_051350.1:g.11del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004959.5" sequenceAccession="NM_004959" sequenceVersion="5" change="c.18del" MANESelect="true">
            <Expression>NM_004959.5:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004950.2" sequenceAccession="NP_004950" sequenceVersion="2" change="p.Asp6fs">
            <Expression>NP_004950.2:p.Asp6fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA122714" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="184757.0006" DB="OMIM" />
        <XRef Type="rs" ID="606231205" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004959.5(NR5A1):c.18del (p.Asp6fs) AND 46,XY sex reversal 3" Accession="RCV000013643" Version="20">
        <ClassifiedConditionList TraitSetID="6711">
          <ClassifiedCondition DB="MedGen" ID="C3489793">46,XY sex reversal 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-11-17" MostRecentSubmission="2017-11-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15579739</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6711" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6630" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, PARTIAL OR COMPLETE, NR5A1-RELATED</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR5A1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR5A1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SEX REVERSAL, XY, WITH OR WITHOUT ADRENAL FAILURE</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, WITH OR WITHOUT ADRENAL FAILURE</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DISORDER OF SEX DEVELOPMENT, 46,XY, NR5A1-RELATED</ElementValue>
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 3</ElementValue>
                <XRef ID="MONDO:0013066" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY3</ElementValue>
                <XRef ID="GTR000528538" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="612965" DB="OMIM" />
              </Symbol>
              <Citation Type="Position Statement" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C3489793" DB="MedGen" />
              <XRef ID="MONDO:0013066" DB="MONDO" />
              <XRef Type="MIM" ID="612965" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33890" SubmissionDate="2017-11-14" DateLastUpdated="2017-11-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="184757.0006_46,XY SEX REVERSAL 3" title="NR5A1, 1-BP DEL, 18C_46,XY SEX REVERSAL 3" />
        <ClinVarAccession Accession="SCV000033890" DateUpdated="2017-11-17" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Hasegawa et al. (2004) identified an SF1 mutation in a 27-year-old Japanese patient with a 46,XY karyotype and complete gonadal dysgenesis (SRXY3; 612965). Sequence analysis of all 7 exons of SF1 revealed a heterozygous 1-bp deletion at exon 2, 18delC, that was predicted to cause a frameshift at codon 6 and result in termination at codon 74 (Asp6fsTer74). Western blot analysis demonstrated no evidence of an amino-truncated SF1 protein despite the 18delC mutation being very close to the natural translation start codon. Transcription analysis indicated that the mutant was transcriptionally inactive and had no dominant-negative effect. Clinical features included small dysgenetic testes with vasa deferentia and epididymides, absent uterus, blind-ending vagina, and clitoromegaly. The authors concluded that SF1 haploinsufficiency can selectively impair testicular development and permit the biosynthesis of AMH (600957) and testosterone in dysgenetic testes and the production of gonadotropins in pituitary gonadotropes.</Attribute>
              <Citation>
                <ID Source="PubMed">15579739</ID>
              </Citation>
              <XRef DB="OMIM" ID="612965" Type="MIM" />
              <XRef DB="OMIM" ID="600957" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR5A1" />
          </GeneList>
          <Name>NR5A1, 1-BP DEL, 18C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 18C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="184757.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">46,XY SEX REVERSAL 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33890" TraitType="Disease" MappingType="Name" MappingValue="46,XY SEX REVERSAL 3" MappingRef="Preferred">
        <MedGen CUI="C3489793" Name="46,XY sex reversal 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

